Progress and challenges in the global effort against cancerBRODER, S.Journal of cancer research and clinical oncology. 1991, Vol 117, Num 4, pp 290-294, issn 0171-5216Conference Paper

Clinical application of 3'-azido-2',3'-dideoxythymidine (AZT) and related dideoxynucleosidesBRODER, S.Medicinal research reviews (Print). 1990, Vol 10, Num 4, pp 419-439, issn 0198-6325Article

Strategies for experimental therapy of the retrovirus which causes AIDSBRODER, S.Annales de l'Institut Pasteur. Virologie. 1987, Vol 138, Num 1, pp 49-59, issn 0769-2617Article

HOMOLOGOUS ARTIFICIAL INSEMINATION AFTER LONG-TERM SEMEN CRYOPRESERVATIONFRIEDMAN S; BRODER S.1981; FERTIL. STRIL.; ISSN 0015-0282; USA; DA. 1981; VOL. 35; NO 3; PP. 321-324; BIBL. 4 REF.Article

T Cell proliferation and ablation: a biologic spectrum of abnormalities induced by the human T cell lymphotropic virus groupBRODER, S.Progress in allergy. 1986, Vol 37, pp 224-243, issn 0079-6034Article

The challenge of cancer researchBRODER, S.Stem cells (Dayton, OH). 1993, Vol 11, Num 1, pp 3-8, issn 1066-5099Article

Dideoxycytidine (ddc) : a potent antiretroviral agent for human immunodeficiency virus infection, February 3, 1990, San Francisco CABRODER, S.The American journal of medicine. 1990, Vol 88, issn 0002-9343, 35 p., Suppl. 5BConference Proceedings

CUTANEOUS T-CELL LYMPHOMASBRODER S; BUNN PA JR.1980; SEMIN. ONCOL.; USA; DA. 1980; VOL. 7; NO 3; PP. 310-331; BIBL. 153 REF.Article

Symposium on HTLV, december 6-7, 1984 Bethesda MDBRODER, S.Cancer research (Baltimore). 1985, Vol 45, Num 9, issn 0008-5472, 191 p.Conference Proceedings

FC-RECEPTORS ON HUMAN T LYMPHOCYTES. I: TRANSITION OF TGAMMA TO TMU CELLSPICHLER WJ; LUM L; BRODER S et al.1978; J. IMMUNOL.; USA; DA. 1978; VOL. 121; NO 4; PP. 1540-1548; BIBL. 30 REF.Article

STRATEGIES FOR MEASUREMENT OF DIFFERENT ASPECTS OF SELF-DISCLOSURE.ANCHOR KN; CHERONES J; BRODER S et al.1977; PSYCHOL. REP.; U.S.A.; DA. 1977; VOL. 41; NO 1; PP. 173-174; BIBL. 8 REF.Article

A MONOCLONAL ANTIBODY (ANTI-TAC) REACTIVE WITH ACTIVATED AND FUNCTIONALLY MATURE HUMAN T CELLS. I: PRODUCTION OF ANTI-TAC MONOCLONAL ANTIBODY AND DISTRIBUTION OF TAC(+) CELLSUCHIYAMA T; BRODER S; WALDMANN TA et al.1981; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1981; VOL. 126; NO 4; PP. 1393-1397; BIBL. 33 REF.Article

SUPPRESSOR CELLS IN NEOPLASTIC DISEASEBRODER S; MUUL L; WALDMANN TA et al.1978; J. NATION. CANCER INST.; USA; DA. 1978; VOL. 61; NO 1; PP. 5-11; BIBL. 81 REF.Article

CURRENT CONCEPTS IN IMMUNOREGULATORY T-CELL NEOPLASMSBRODER S; UCHIYAMA T; WALDMANN TA et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 4; PP. 607-612; BIBL. 19 REF.Article

METABOLIC HETEROGENEITY OF EOSINOPHILS FROM NORMAL AND HYPEREOSINOPHILIC PATIENTSPINCUS SH; SCHOOLEY WR; DINAPOLI AM et al.1981; BLOOD; ISSN 0006-4971; USA; DA. 1981; VOL. 58; NO 6; PP. 1175-1181; BIBL. 19 REF.Article

New directions in molecular medicineKARP, J. E; BRODER, S.Cancer research (Baltimore). 1994, Vol 54, Num 3, pp 653-665, issn 0008-5472Article

Oncology and hematologyKARP, J. E; BRODER, S.JAMA, the journal of the American Medical Association. 1994, Vol 271, Num 21, pp 1693-1695, issn 0098-7484Article

Anti-retroviral therapy of AIDS and related disorders: general principles and specific development of dideoxynucleosidesYARCHOAN, R; BRODER, S.Pharmacology & therapeutics (Oxford). 1989, Vol 40, Num 3, pp 329-348, issn 0163-7258Article

Inhibition of infectivity and replication of HIV-2 and SIV in helper T-cells by 2',3'-dideoxynucleosides in vitroMITSUYA, H; BRODER, S.AIDS research and human retroviruses. 1988, Vol 4, Num 2, pp 107-113, issn 0889-2229Article

FC RECEPTORS ON HUMAN T LYMPHOCYTES. V: EFFECTS OF COLCHICINE AND CYTOCHALASIN B ON FC RECEPTOR EXPRESSIONREAMAN GH; POPLACK DG; BRODER S et al.1980; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1980; VOL. 125; NO 5; PP. 2215-2219; BIBL. 31 REF.Article

Progress against cancerBRODER, S; KARP, J. E.Journal of cancer research and clinical oncology. 1995, Vol 121, Num 11, pp 633-647, issn 0171-5216Conference Paper

Dideoxycytidine : current clinical experience and future prospects : a summaryBRODER, S; YARCHOAN, R.The American journal of medicine. 1990, Vol 88, pp 5B.31S-5B.33S, issn 0002-9343, Suppl. 5BConference Paper

CHEMOTHERAPY FOR LYMPHOMA IN A PATIENT WITH COMMON VARIABLE IMMUNODEFICIENCY: CASE REPORT, LITERATURE REVIEW, AND RECOMMENDATIONS FOR CHEMOTHERAPY IN IMMUNODEFICIENT PATIENTSGELMANN E; ANDERSON T; JAFFE E et al.1982; ARCH. INTERN. MED. (1960); ISSN 0003-9926; USA; DA. 1982; VOL. 142; NO 1; PP. 90-92; BIBL. 15 REF.Article

F(AB)₂-LIKE IMMUNOGLOBULIN FRAGMENTS IN URINES FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS = FRAGMENTS D'IMMUNOGLOBULINES DU TYPE F(AB)₂ DANS LES URINES DES MALADES ATTEINTS DE LUPUS ERYTHEMATEUX GENERALISEBRODER S; CASSIDY JT; GOLDBERG CB et al.1972; J. LAB. CLIN. MED.; U.S.A.; DA. 1972; VOL. 80; NO 4; PP. 514-522; BIBL. 2P.1/2Serial Issue

Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosidesMITSUYA, H; BRODER, S.Proceedings of the National Academy of Sciences of the United States of America. 1986, Vol 83, Num 6, pp 1911-1915, issn 0027-8424Article